TABLE 2.

Clinical description and results obtained for solid organ transplant patients^a

Patient no.	Transplant type	Serological status of donor	IgG antibody titer (IU/ml) (wks post-TP)	Clinical symptoms	IgG-AI
1	Heart	+	21 (0)		0.70
			273 (4)	Disseminated toxoplasmosisb	0.58
			364 (6)	Death	0.48
2	Heart	+	753 (0)	None	0.57
			153 (2)		0.46
			1,038 (11)		0.81
3	Liver-lung	−	212 (0)	None	0.70
			446 (10)		0.60
			772 (12)		0.50
			1,354 (19)		0.52
			261 (24)		0.52
4	Liver-kidney	−	130 (0)	None	0.72
			2,260 (1)		0.73
			>2,400 (3)		0.78
			>2,400 (8)		0.74
5	Heart	NA	106 (0)	None	0.50
			820 (4)		0.60
			1,360 (6)		0.59
			1,110 (8)		0.62

^an = 5. Abbreviations: NA, not available; TP, transplantation. 

^bProbably transmitted by the donor, as attested by anatomopathological signs of evolutive toxoplasmic myocarditis, detection of circulating parasites by PCR, and appearance of newly synthesized IgG isotypes by Western blot analysis (F. Robert-Gangneux et al., submitted for publication).